Optimizing Treatment Strategies for Advanced Upper GI Cancers : Episode 7

Megan’s Journey With HER2+ Upper GI Cancer

March 21, 2025

Opinion

Video

Experts discuss Megan’s journey with HER2+ upper gastrointestinal (GI) cancer, highlighting key treatment strategies and challenges.

EP: 1.Navigating Immune-Related Adverse Events With Nivolumab in Upper GI Cancer

EP: 2.Robert’s Journey With HER2- Upper GI Cancer

EP: 3.Strategies for Managing FOLFOX Toxicity in Upper GI Cancer

EP: 4.Supporting Patients Through Treatment for Upper GI Cancer Care

EP: 5.Communicating Treatment Adverse Effects: Strategies for Managing Expectations During Treatment for Upper GI Cancer

EP: 6.Balancing Treatment Intensity and Quality of Life in Upper GI Cancer

Now Viewing

EP: 7.Megan’s Journey With HER2+ Upper GI Cancer

EP: 8.Managing Adverse Events With Trastuzumab Deruxtecan: Early Detection and ILD Monitoring Strategies

EP: 9.Managing Symptoms and Quality of Life During HER2-Targeted Therapy for Upper GI Cancer

EP: 10.Multidisciplinary Collaboration in Managing Treatment-Related AEs in Upper GI Cancer

EP: 11.Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer Treatment

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!

Latest Conference Coverage

Safety Management With Amivantamab Plus Lazertinib in NSCLC

Tepotinib Shows Manageable Safety in MET Exon 14+ NSCLC

Adverse Events of Menin Inhibitors in AML: What Nurses Should Know

Ivonescimab/Chemo Ups PFS After Third-Generation TKI in EGFR+ NSCLC

View More Latest Conference Coverage

Do Not Sell My Information

Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

609-716-7777